CN107913300A - A kind of formula for treating poultry influenza ewcastle disease - Google Patents

A kind of formula for treating poultry influenza ewcastle disease Download PDF

Info

Publication number
CN107913300A
CN107913300A CN201810054496.9A CN201810054496A CN107913300A CN 107913300 A CN107913300 A CN 107913300A CN 201810054496 A CN201810054496 A CN 201810054496A CN 107913300 A CN107913300 A CN 107913300A
Authority
CN
China
Prior art keywords
formula
resibufogenin
distillate
content
bufalin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810054496.9A
Other languages
Chinese (zh)
Inventor
张显英
马超群
何晓霞
马新华
郭鑫
齐青山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Pastoral Biotechnology Co Ltd
Original Assignee
Henan Pastoral Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Pastoral Biotechnology Co Ltd filed Critical Henan Pastoral Biotechnology Co Ltd
Priority to CN201810054496.9A priority Critical patent/CN107913300A/en
Publication of CN107913300A publication Critical patent/CN107913300A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of formula for treating poultry influenza ewcastle disease, it includes formula composition composition and content, the formula composition composition is Bufalin, magnificent toadpoison poison base, resibufogenin, cantharidin and radix stellariae dichotomae distillate, the content is containing 1 7mg of Bufalin, magnificent 5 12mg of toadpoison poison base, 5 40mL of 0.5 4mg of resibufogenin, 1 15mg of cantharidin and radix stellariae dichotomae distillate, remaining purified water in every 100mL solution；Therefore, the present invention has the advantages that pure Chinese medicine, no drug residue, good without off-drug period and therapeutic effect.

Description

A kind of formula for treating poultry influenza ewcastle disease
Technical field
The invention belongs to the technical field of poultry disease, and in particular to a kind of formula for treating poultry influenza ewcastle disease.
Background technology
With the continuous development of society, the development of aquaculture is also more and more extensive, and in recent years, the epidemic disease such as poultry influenza goes out Now aquaculture is undoubtedly once inflicted heavy losses on, the epidemic disease such as poultry influenza can cause poultry dead, also there are some treatments in the prior art The medicine of poultry disease, but mostly there are more or less shortcoming, for example, high residue, it is high it is carcinogenic, be not pure Chinese medicine, Western medicine etc.；For these problems, it is necessary to develop a kind of pure Chinese medicine, no drug residue, without the good treatment of off-drug period and therapeutic effect The formula of poultry influenza ewcastle disease；Therefore, a kind of pure Chinese medicine, no drug residue are developed, without off-drug period and therapeutic effect good treatment man The formula tool of bird flu ewcastle disease is of great significance.
The content of the invention
The purpose of the invention is to overcome the shortcomings of poultry influenza Epidemic disease prevention and treatment in poultry farming, and provide A kind of pure Chinese medicine, no drug residue, the formula without off-drug period and therapeutic effect good treatment poultry influenza ewcastle disease.
The object of the present invention is achieved like this：A kind of formula for treating poultry influenza ewcastle disease, it includes formula composition Composition and content, the formula composition composition is Bufalin, magnificent toadpoison poison base, resibufogenin, cantharidin and radix stellariae dichotomae distill Liquid, the content are per 1-7mg containing Bufalin, magnificent toadpoison poison base 5-12mg, resibufogenin 0.5-4mg, spot in 100mL solution Chinese blister beetle element 1-15mg and radix stellariae dichotomae distillate 5-40mL, remaining is purified water.
The content is per 4mg containing Bufalin, magnificent toadpoison poison base 8mg, resibufogenin 2.5mg, Chinese blister beetle in 100mL solution Plain 8mg and radix stellariae dichotomae distillate 25mL, remaining is purified water.
The content is per 1mg containing Bufalin, magnificent toadpoison poison base 5mg, resibufogenin 0.5mg, Chinese blister beetle in 100mL solution Plain 1mg and radix stellariae dichotomae distillate 5mL, remaining is purified water.
The content is per 7mg containing Bufalin, magnificent toadpoison poison base 12mg, resibufogenin 4mg, Chinese blister beetle in 100mL solution Plain 15mg and radix stellariae dichotomae distillate 40mL, remaining is purified water.
The 100mL solution supplies the poultry of 1000-2000 kg body weights.
Beneficial effects of the present invention：Formula components in the present invention use pure Chinese medicine, have no drug residue and without the off-drug period Advantage, has remarkable result in terms of influenza is prevented and treated, and formulation manufacturing process is simple, easily production；Therefore, it is of the invention There is pure Chinese medicine, no drug residue, good without off-drug period and therapeutic effect.
Embodiment
Embodiment 1
A kind of formula for treating poultry influenza ewcastle disease, it includes formula composition composition and content, and the formula composition composition is Bufalin, magnificent toadpoison poison base, resibufogenin, cantharidin and radix stellariae dichotomae distillate, the content is to contain toad per in 100mL solution Malicious spirit 1-7mg, magnificent toadpoison poison base 5-12mg, resibufogenin 0.5-4mg, cantharidin 1-15mg and radix stellariae dichotomae distillate 5- 40mL, remaining is purified water.
Formula components in the present invention use pure Chinese medicine, have the advantages that no drug residue and without the off-drug period, are preventing and treating The aspect of influenza has remarkable result, and formulation manufacturing process is simple, easily production；Poultry uses, and continuous oral 1-3 days is It can take effect；This formula also has reduction cultivation risk, improves culture benefit；Therefore, the present invention has pure Chinese medicine, no drug residue, nothing The advantages of off-drug period and good therapeutic effect.
Embodiment 2
A kind of formula for treating poultry influenza ewcastle disease, it includes formula composition composition and content, and the formula composition composition is Bufalin, magnificent toadpoison poison base, resibufogenin, cantharidin and radix stellariae dichotomae distillate, the content is to contain toad per in 100mL solution Malicious spirit 1-7mg, magnificent toadpoison poison base 5-12mg, resibufogenin 0.5-4mg, cantharidin 1-15mg and radix stellariae dichotomae distillate 5- 40mL, remaining is water, and the content is per 4mg containing Bufalin, magnificent toadpoison poison base 8mg, resibufogenin in 100mL solution 2.5mg, cantharidin 8mg and radix stellariae dichotomae distillate 25mL, remaining is water, and the content is to contain Bufalin per in 100mL solution 1mg, magnificent toadpoison poison base 5mg, resibufogenin 0.5mg, cantharidin 1mg and radix stellariae dichotomae distillate 5mL, remaining is water, described to contain Measure as 7mg containing Bufalin, magnificent toadpoison poison base 12mg, resibufogenin 4mg, cantharidin 15mg and radix stellariae dichotomae in every 100mL solution Distillate 40mL, remaining is water, and the 100mL solution supplies the poultry of 1000-2000 kg body weights.
Embodiment is unrestricted to further explanation of the invention, is existed for those of ordinary skills Further conversion is done in the case of not departing from substantive content of the present invention to structure, and all these conversion should all belong to institute of the present invention Attached scope of the claims.

Claims (5)

1. a kind of formula for treating poultry influenza ewcastle disease, it includes formula composition composition and content, the formula composition composition For Bufalin, magnificent toadpoison poison base, resibufogenin, cantharidin and radix stellariae dichotomae distillate, the content is to contain per in 100mL solution Bufalin 1-7mg, magnificent toadpoison poison base 5-12mg, resibufogenin 0.5-4mg, cantharidin 1-15mg and radix stellariae dichotomae distillate 5- 40mL, remaining purified water.
A kind of 2. formula for treating poultry influenza ewcastle disease according to claim 1, it is characterised in that：The content is every 4mg containing Bufalin, magnificent toadpoison poison base 8mg, resibufogenin 2.5mg, cantharidin 8mg and radix stellariae dichotomae distillate in 100mL solution 25mL, remaining purified water.
A kind of 3. formula for treating poultry influenza ewcastle disease according to claim 1, it is characterised in that：The content is every 1mg containing Bufalin, magnificent toadpoison poison base 5mg, resibufogenin 0.5mg, cantharidin 1mg and radix stellariae dichotomae distillate in 100mL solution 5mL, remaining is purified water.
A kind of 4. formula for treating poultry influenza ewcastle disease according to claim 1, it is characterised in that：The content is every 7mg containing Bufalin, magnificent toadpoison poison base 12mg, resibufogenin 4mg, cantharidin 15mg and radix stellariae dichotomae distillate in 100mL solution 40mL, remaining is purified water.
A kind of 5. formula for treating poultry influenza ewcastle disease according to claim 1, it is characterised in that：The 100mL is molten Liquid supplies the poultry of 1000-2000 kg body weights.
CN201810054496.9A 2018-01-19 2018-01-19 A kind of formula for treating poultry influenza ewcastle disease Pending CN107913300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810054496.9A CN107913300A (en) 2018-01-19 2018-01-19 A kind of formula for treating poultry influenza ewcastle disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810054496.9A CN107913300A (en) 2018-01-19 2018-01-19 A kind of formula for treating poultry influenza ewcastle disease

Publications (1)

Publication Number Publication Date
CN107913300A true CN107913300A (en) 2018-04-17

Family

ID=61891405

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810054496.9A Pending CN107913300A (en) 2018-01-19 2018-01-19 A kind of formula for treating poultry influenza ewcastle disease

Country Status (1)

Country Link
CN (1) CN107913300A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110600A1 (en) * 2001-02-15 2002-08-15 John Voorhees Composition for treating symptoms of influenza
CN102657759A (en) * 2012-06-01 2012-09-12 天津生机集团股份有限公司 Chinese medicinal granules for treating poultry influenza or common cold
CN107308169A (en) * 2017-07-07 2017-11-03 黄志敏 A kind of pharmaceutical composition with antivirus action

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110600A1 (en) * 2001-02-15 2002-08-15 John Voorhees Composition for treating symptoms of influenza
CN102657759A (en) * 2012-06-01 2012-09-12 天津生机集团股份有限公司 Chinese medicinal granules for treating poultry influenza or common cold
CN107308169A (en) * 2017-07-07 2017-11-03 黄志敏 A kind of pharmaceutical composition with antivirus action

Similar Documents

Publication Publication Date Title
BR112015016796A8 (en) androgen receptor modulator, pharmaceutical composition comprising them and uses thereof
BR0308196A (en) Compound, pharmaceutical formulation, use of a compound, methods for preventing and / or treating conditions associated with glycogen synthase kinase-3, and disease, and process for preparing a compound
BRPI0408559A (en) dispersible pharmaceutical compositions for the treatment of mastitis and optical disorders
Rauf et al. Preclinical profile of bacopasides from Bacopa monnieri (BM) as an emerging class of therapeutics for management of chronic pains
RU2007138867A (en) TRANS-CLOMIPHENE DOSAGE MODES
HUP0301828A2 (en) Use of apomorphine for the production of pharmaceutical compositions for treating sexual dysfunction with apomorphine at specified plasma concentration levels
CN101474284B (en) External use medicament for treating fungal dermatopathy
CN107913300A (en) A kind of formula for treating poultry influenza ewcastle disease
CN103585271A (en) Anti-bacterial disinfectant
CN1965844A (en) Nasal administered pharmaceutical composition containing glycyrrhetic acid and medical use thereof
CN109464328A (en) Plant type bacterio static itching-relieving liquid
CN104306402A (en) Traditional Chinese medicine composition for treating burn and scald infection and preparation method thereof
BRPI0410657A (en) compound, pharmaceutical composition, use of a compound, method for treating a disorder of a patient, and process for preparing a compound
CL2004000631A1 (en) COMPOUNDS DERIVED FROM ACID 6- (2-BROMOFENIL) -PIRIDO [2,3-DIPIRIMIDIN-7-CARBOXILICO; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND USE TO TREAT CANCER AND TO PREPARE MEDICATIONS TO INHIBIT TUMOR GROWTH.
CN107080790A (en) It is a kind of to be used for fracture recovering or the rehabilitation medicine formula of damage soft tissue
CN104147197A (en) Medicine for treating tinea pedis and preparation method thereof
CN108853300A (en) It is a kind of for arthralgia and myalgia and the exterior-applied medical wine of bacterio static itching-relieving
CN110368429A (en) Prevent and treat the Chinese medicine composition and preparation method thereof that bacillary enterogastritis draws dysentery
CN109464455A (en) A kind of creme for preventing and treating pet body surface bacterium and fungi
CN1989976A (en) Effective therapeutic agent for ringworm of the nails
JP2007332126A (en) Anti-ringworm bath agent for human and pet animal
CN104351223A (en) Method for preventing and treating lily leaf blight
CN109276633A (en) A kind of alleviation osteoproliferation ointment
BRPI0514729A (en) treatment of t-cell modulation hiv infection
CN1045534C (en) Compound medicine for treating wart

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180417